These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 20351187

  • 1. The protein moiety of Brucella abortus outer membrane protein 16 is a new bacterial pathogen-associated molecular pattern that activates dendritic cells in vivo, induces a Th1 immune response, and is a promising self-adjuvanting vaccine against systemic and oral acquired brucellosis.
    Pasquevich KA, García Samartino C, Coria LM, Estein SM, Zwerdling A, Ibañez AE, Barrionuevo P, Oliveira FS, Carvalho NB, Borkowski J, Oliveira SC, Warzecha H, Giambartolomei GH, Cassataro J.
    J Immunol; 2010 May 01; 184(9):5200-12. PubMed ID: 20351187
    [Abstract] [Full Text] [Related]

  • 2. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.
    Infect Immun; 2009 Jan 01; 77(1):436-45. PubMed ID: 18981242
    [Abstract] [Full Text] [Related]

  • 3. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J, Estein SM, Pasquevich KA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH.
    Infect Immun; 2005 Dec 01; 73(12):8079-88. PubMed ID: 16299302
    [Abstract] [Full Text] [Related]

  • 4. An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice.
    Pasquevich KA, Ibañez AE, Coria LM, García Samartino C, Estein SM, Zwerdling A, Barrionuevo P, Oliveira FS, Seither C, Warzecha H, Oliveira SC, Giambartolomei GH, Cassataro J.
    PLoS One; 2011 Jan 14; 6(1):e16203. PubMed ID: 21264260
    [Abstract] [Full Text] [Related]

  • 5. Intradermal immunization with outer membrane protein 25 protects Balb/c mice from virulent B. abortus 544.
    Goel D, Bhatnagar R.
    Mol Immunol; 2012 Jun 14; 51(2):159-68. PubMed ID: 22464098
    [Abstract] [Full Text] [Related]

  • 6. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
    Paul S, Peddayelachagiri BV, Nagaraj S, Kingston JJ, Batra HV.
    Mol Immunol; 2018 Jul 14; 99():9-18. PubMed ID: 29649688
    [Abstract] [Full Text] [Related]

  • 7. Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis.
    Mallick AI, Singha H, Khan S, Anwar T, Ansari MA, Khalid R, Chaudhuri P, Owais M.
    Vaccine; 2007 Nov 14; 25(46):7873-84. PubMed ID: 17931756
    [Abstract] [Full Text] [Related]

  • 8. Oral immunization of mice with Omp31-loaded N-trimethyl chitosan nanoparticles induces high protection against Brucella melitensis infection.
    Abkar M, Fasihi-Ramandi M, Kooshki H, Sahebghadam Lotfi A.
    Int J Nanomedicine; 2017 Nov 14; 12():8769-8778. PubMed ID: 29263667
    [Abstract] [Full Text] [Related]

  • 9. Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection.
    Tabynov K, Sansyzbay A, Kydyrbayev Z, Yespembetov B, Ryskeldinova S, Zinina N, Assanzhanova N, Sultankulova K, Sandybayev N, Khairullin B, Kuznetsova I, Ferko B, Egorov A.
    Virol J; 2014 Apr 10; 11():69. PubMed ID: 24716528
    [Abstract] [Full Text] [Related]

  • 10. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
    Abkar M, Lotfi AS, Amani J, Eskandari K, Ramandi MF, Salimian J, Brujeni GN, Alamian S, Kamali M, Koushki H.
    Vet Res Commun; 2015 Dec 10; 39(4):217-28. PubMed ID: 26395469
    [Abstract] [Full Text] [Related]

  • 11. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J, Pasquevich KA, Estein SM, Laplagne DA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH, Goldbaum FA.
    Vaccine; 2007 May 30; 25(22):4437-46. PubMed ID: 17442465
    [Abstract] [Full Text] [Related]

  • 12. Oral delivery of Brucella spp. recombinant protein U-Omp16 abrogates the IgE-mediated milk allergy.
    Smaldini PL, Ibañez AE, Fossati CA, Cassataro J, Docena GH.
    Hum Vaccin Immunother; 2014 May 30; 10(7):2015-23. PubMed ID: 25424811
    [Abstract] [Full Text] [Related]

  • 13. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J, Walravens K, Letesson JJ.
    Infect Immun; 2001 Aug 30; 69(8):4816-22. PubMed ID: 11447155
    [Abstract] [Full Text] [Related]

  • 14. Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection.
    Tabynov K, Kydyrbayev Z, Ryskeldinova S, Yespembetov B, Zinina N, Assanzhanova N, Kozhamkulov Y, Inkarbekov D, Gotskina T, Sansyzbay A.
    Vaccine; 2014 Apr 11; 32(18):2034-41. PubMed ID: 24598723
    [Abstract] [Full Text] [Related]

  • 15. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
    Delpino MV, Estein SM, Fossati CA, Baldi PC, Cassataro J.
    Vaccine; 2007 Sep 17; 25(37-38):6721-9. PubMed ID: 17686554
    [Abstract] [Full Text] [Related]

  • 16. Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.
    Zhao Z, Li M, Luo D, Xing L, Wu S, Duan Y, Yang P, Wang X.
    Vaccine; 2009 Aug 20; 27(38):5214-9. PubMed ID: 19596411
    [Abstract] [Full Text] [Related]

  • 17. Outer membrane protein A of Acinetobacter baumannii induces differentiation of CD4+ T cells toward a Th1 polarizing phenotype through the activation of dendritic cells.
    Lee JS, Lee JC, Lee CM, Jung ID, Jeong YI, Seong EY, Chung HY, Park YM.
    Biochem Pharmacol; 2007 Jun 30; 74(1):86-97. PubMed ID: 17482145
    [Abstract] [Full Text] [Related]

  • 18. High protection of mice against Brucella abortus by oral immunization with recombinant probiotic Lactobacillus casei vector vaccine, expressing the outer membrane protein OMP19 of Brucella species.
    Mohammadi E, Golchin M.
    Comp Immunol Microbiol Infect Dis; 2020 Jun 30; 70():101470. PubMed ID: 32208191
    [Abstract] [Full Text] [Related]

  • 19. Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice.
    Luo D, Ni B, Li P, Shi W, Zhang S, Han Y, Mao L, He Y, Wu Y, Wang X.
    Infect Immun; 2006 May 30; 74(5):2734-41. PubMed ID: 16622210
    [Abstract] [Full Text] [Related]

  • 20. Intraperitoneal administration of a novel chimeric immunogen (rOP) elicits IFN-γ and IL-12p70 protective immune response in BALB/c mice against virulent Brucella.
    Tadepalli G, Konduru B, Murali HS, Batra HV.
    Immunol Lett; 2017 Dec 30; 192():79-87. PubMed ID: 29106986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.